Monkeypox virus vaccine evolution and global preparedness for vaccination.

• Recently, the emergence of MPX has created a global threat, and vaccination is one of the significant ways to fight against the virus. • The article describes the important points and issues for vaccines and vaccinations related to the MPXV. • It also illustrates significant research on the MPXV, especially smallpox vaccines, and its outcome in MPX infection. • Vaccination preparedness has been illustrated in various countries like the USA, UK, Canada, Denmark, Germany, etc. The recent emergence of monkeypox (MPX) has created a global threat. The number of infected and suspected cases of MPX is increasing in different parts of the world, especially in non-African countries. However, vaccines are available to fight against this disease. It has been observed that smallpox vaccines can be used to protect against MPX. The present article highlights the significant points and various issues for vaccines and vaccinations that should be considered related to MPX. This paper illustrates current vaccines for smallpox that can be utilized to protect against MPX infection. The article also describes the different significant research on MPXV, especially smallpox vaccines, and its outcome in MPX infection. We have also tried to depict the smallpox vaccination eradication model through the statistical interface using smallpox eradication data from Central and West Africa between 1967 and 1972. We suggest that these models might be helpful for the eradication of MPX in the middle to low-economic countries. Simultaneously, we have also discussed vaccination preparedness in different countries like the USA, UK, Canada, Denmark, Germany, etc. Our report might be helpful to scientists and policymakers in understanding the vaccines and vaccination against MPX and formulating effective strategies to fight against the disease. [ABSTRACT FROM AUTHOR]